# Cleo Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cleo-labs

- Industry: Healthcare Specialists
- Headquarters: San Francisco, US
- Website: www.hicleo.com
- Total disclosed funding: $80M
- Latest round: Series C (Mar 5, 2021)
- Investors on record: 8

## About

Based in California, US, and founded in 2016, Cleo Labs, Inc. is a family benefits platform. Chitra Akileswaran, MD, is the co-founder and current Chief Medical Officer of the company. Sarahjane Sacchetti is the current Cleo Labs' CEO. In March 2021, Cleo Labs, Inc. raised USD 40 million in a Series C funding led by new investor Transformation Capital, with participation from other new investors.

The company offers a family support system that provides parenthood guidance and coaching through a mobile app. It offers help with pregnancy, infant care, childcare, emotional support, parenting, returning to work, sleep training, career coaching, marriage, and family therapy that compliments the existing medical support. It also enables users to make appointments through video chat and messaging. Cleo proactively identifies risk factors, intervenes early, and provides ongoing, personalized support to employers, consultants, and families.

The company plans to expand its support to more working parents, expand its marketplace to address diverse family needs, and offer more enhanced clinical programs to drive improved health outcomes.

## Funding rounds

- Series C, Mar 5, 2021, $40M — New Enterprise Associates, Greylock Partners, Felicis Ventures, Glynn Capital, Transformation Capital, Gaingels, PruVen Capital
- Series B, Mar 20, 2019, $28M — New Enterprise Associates
- Series A, Jun 13, 2018, $11M — Greylock Partners, Forerunner Ventures, Felicis Ventures
- Seed, Mar 2, 2017, $2.3M — Forerunner Ventures, Felicis Ventures

## Investors

- Forerunner Ventures (https://capitalatlas.ai/funds/forerunner-ventures) — Seed, Series A
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Seed, Series A, Series C
- Greylock Partners (https://capitalatlas.ai/funds/greylock-partners) — Series A, Series C
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B, Series C
- Glynn Capital (https://capitalatlas.ai/funds/glynn-capital) — Series C
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series C
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series C
- PruVen Capital (https://capitalatlas.ai/funds/pruven-capital) — Series C